UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Survivin is a negative prognostic factor in malignant pleural effusion

European journal of clinical investigation, 2018-04, Vol.48 (4), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

British journal of cancer, 2022-12, Vol.127 (12), p.2234-2240

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

British journal of cancer, 2019-02, Vol.120 (4), p.473-474

2019

Link zum Volltext

Verfügbarkeit prüfen

Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

PloS one, 2023-05, Vol.18 (5), p.e0266305-e0266305

2023

Link zum Volltext

Verfügbarkeit prüfen

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry

Cancers, 2023-03, Vol.15 (7), p.2034

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

Frontiers in cardiovascular medicine, 2023-05, Vol.10, p.1118385-1118385

2023

Link zum Volltext

Verfügbarkeit prüfen

Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review

Journal of personalized medicine, 2022-05, Vol.12 (6), p.863

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

Cancers, 2020-08, Vol.12 (8), p.2267

2020

Link zum Volltext

Verfügbarkeit prüfen

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

Cancers, 2021-05, Vol.13 (11), p.2517

2021

Link zum Volltext

Verfügbarkeit prüfen

High correlation between 2 flow cytometry platforms in the microparticles analysis using a new calibrated beads strategy

Translational research : the journal of laboratory and clinical medicine, 2015-12, Vol.166 (6), p.733-739

2015

Link zum Volltext

Verfügbarkeit prüfen

Factores predictores de trombosis en pacientes con cáncer

Archivos de bronconeumología, 2019-02, Vol.55 (2), p.67-68

2019

Link zum Volltext

Verfügbarkeit prüfen

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2019-10, Vol.20 (10), p.e566-e581

2019

Link zum Volltext

Verfügbarkeit prüfen

Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension

International journal of medical sciences, 2023-01, Vol.20 (10), p.1336-1338

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD

International journal of chronic obstructive pulmonary disease, 2019-06, Vol.14, p.1323-1332

2019

Link zum Volltext

Verfügbarkeit prüfen

Nutriepigenomics and chronic obstructive pulmonary disease: potential role of dietary and epigenetics factors in disease development and management

The American journal of clinical nutrition, 2021-12, Vol.114 (6), p.1894-1906

2021

Link zum Volltext

Verfügbarkeit prüfen

Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review

Thrombosis research, 2023-12, Vol.232, p.151-159

2023

Link zum Volltext

Verfügbarkeit prüfen

Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism

Chest, 2024-03, Vol.165 (3), p.673-681

2024

Link zum Volltext

Verfügbarkeit prüfen

Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

Chest, 2024-03, Vol.165 (3), p.673-681

2024

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis of Venous Thromboembolism

Archivos de bronconeumología (English ed.), 2008-03, Vol.44 (3), p.160-169

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Thrombosis in Cancer Patients

Archivos de bronconeumología (English ed.), 2019-02, Vol.55 (2), p.67-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

Archivos De Bronconeumologia, 2022-04, Vol.58, p.39-50

2022

Link zum Volltext

Verfügbarkeit prüfen

Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study

American journal of clinical pathology, 2024-05, Vol.161 (5), p.501-511

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

Research and practice in thrombosis and haemostasis, 2023-02, Vol.7 (2), p.100115, Article 100115

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(63)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Survivin is a negative prognostic factor in malignant pleural effusion

Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

High correlation between 2 flow cytometry platforms in the microparticles analysis using a new calibrated beads strategy

Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study

Factores predictores de trombosis en pacientes con cáncer

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension

Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD

Nutriepigenomics and chronic obstructive pulmonary disease: potential role of dietary and epigenetics factors in disease development and management

Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review

Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism

Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

Prophylaxis of Venous Thromboembolism

Prognostic Factors for Thrombosis in Cancer Patients

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

Suchergebnisse filtern